NCT02185820
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Dipartimento di Biotecnologie Molecolari e Scienze per la Salute Torino, Italy
Clinical trial condition
Hemostatic Disorders
Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.
3,079 public trials
581 recruiting studies
Hemostatic Disorders trial results
NCT01063179
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- A.O.U. S. Giovanni Battista Torino, Italy
NCT03409692
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Turin Turin, Italy
NCT01572662
- Conditions
- Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +39 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Completed
Revlimid And Prednisone Followed By Revlimid, Melphalan And Prednisone In Multiple Myeloma Patients
NCT01160107
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease, +15 more
- Locations
-
Not specified
NCT01166113
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- AOU Città della Salute e della Scienza di Torino - SC Ematologia U Torino, Italy
NCT01348919
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Teva Investigational Site 1 Augusta, Georgia, United States
- Teva Investigational Site 3 Lexington, Kentucky, United States
- Teva Investigational Site 2 Houston, Texas, United States
- Teva Investigational Site 201 Auckland, New Zealand
NCT03681080
- Conditions
- Autonomic Failure, Autonomic Nervous System Diseases, Cardiovascular Diseases, +27 more
- Locations
-
- University Hospital, RWTH Aachen Aachen, North Rhine-Westphalia, Germany
NCT05448196
- Conditions
- Behavior, Behavioral Symptoms, Blood Protein Disorders, +16 more
- Locations
-
- Penn Medicine Philadelphia, Pennsylvania, United States
NCT03364231
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
- Locations
-
- TG Therapeutics Investigational Trial Site Washington D.C., District of Columbia, United States
- TG Therapeutics Investigational Trial Site Boston, Massachusetts, United States
- TG Therapeutics Investigational Trial Site Hackensack, New Jersey, United States
- TG Therapeutics Investigational Trial Site New York, United States